MedTrace Logo

Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment

NCT03940521 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2025-11-17

No results posted yet for this study

Summary

The authors hypothesize that there is a correlation between the percentage of CD4+ T cells expressing CD32a and/or X and the quantity of DNA found in peripheral blood mononuclear cells in patients infected with HIV-1. Also, that there is a correlation between expression of CD32a and/or X and proviral load.

Conditions

Interventions

OTHER

Bioclinical evaluation

50-100ml blood extracted for flow cytometry and qPCR

Sponsors & Collaborators

  • Institut de Génétique Moléculaire de Montpellier

    collaborator OTHER

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Pierre Corbeau, MD · CHU Nimes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-30
Primary Completion
2025-09-30
Completion
2026-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03940521 on ClinicalTrials.gov